Morepen Laboratories Ltd.

View in App
46.11 +1.71 ▲3.9%

16 April 2024, 04:01:00 PM
Volume: 508,819

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.morepen.com
Market Cap 2,357.00 Cr.
Enterprise Value(EV) 2,327.16 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.49 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 30.96 Trailing Twelve Months Ending 2023-12
Industry PE 41.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 16.06 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.87 Calculated using Price: 46.11
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 51.12 Cr. 511,168,708 Shares
FaceValue 2
About Morepen Laboratories Ltd.
Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.

Morepen Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Morepen Laboratories Ltd. Performance

View details >>
1 Day
+3.85%
1 Week
-3.27%
1 Month
+9.89%
3 Month
-4.93%
6 Month
+29.78%
1 Year
+69.40%
2 Year
-3.23%
5 Year
+156.88%
10 Year
+962.44%

Morepen Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.24 7.35 12.54 14.1 12.04 12.5 29.2 21.79 5.93
Return on Capital Employed (%) 2.9 6.29 10.18 14.05 10.01 12.05 27.13 24.86 8.4
Return on Assets (%) 0.44 2.53 4.45 5.3 4.8 5.25 12.76 10.55 3.55

Morepen Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 287 300 196 226 253 284 425 579 753 789
Non Curr. Liab. 74 57 18 20 23 28 30 36 37 39
Curr. Liab. 128 167 325 340 339 351 404 456 321 366
Minority Int. 0 -1 -1 0 0 0 0 0 0 0
Equity & Liab. 489 524 538 586 615 663 858 1,070 1,111 1,194
Non Curr. Assets 374 367 346 342 316 291 331 336 354 378
Curr. Assets 115 157 192 243 299 372 527 734 756 816
Misc. Exp. not W/O
Total Assets 489 524 538 586 615 663 858 1,070 1,111 1,194

Morepen Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 401 485 595 607 769 853 1,188 1,547 1,418 1,631
Other Income 1 1 4 4 4 9 12 20 6 13
Total Income 402 486 599 610 772 863 1,200 1,567 1,424 1,644
Total Expenditure -352 -424 -534 -542 -701 -785 -1,070 -1,410 -1,338 -1,505
PBIDT 50 63 65 68 71 78 131 157 86 139
Interest -9 -11 -8 -4 -2 -2 -2 -2 -2 -3
Depreciation -39 -35 -34 -34 -40 -37 -30 -28 -28 -31
Taxation 0 0 0 -6 -1 -25 -17 -28
Exceptional Items -4
PAT 2 13 24 30 29 34 97 102 39 76
Minority Interest 0 0
Share Associate
Other Related Items
Consolidated Net Profit 2 13 24 30 29 34 97 102 39 76
Adjusted EPS 0 0 1 1 1 1 2 2 1 1

Morepen Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 34 51 50 41 63 17 11 51 -60 -91
Cash Fr. Inv. -1 -32 -27 -14 -27 -13 -12 -70 -32 -47
Cash Fr. Finan. -29 -19 -27 -24 -38 0 5 47 66 144
Net Change 4 0 -4 3 -1 4 4 28 -26 6
Cash & Cash Eqvt 9 9 4 7 6 10 14 41 16 22

Morepen Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 34.54 38.38 36.74 38.22 38.22 38.22 38.22 38.22 38.22
Public 65.46 61.62 63.26 61.78 61.78 61.78 61.78 61.78 61.78
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Morepen Laboratories Ltd. Announcements

View details >>
Tue, 16 Apr 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed intimation of loss of share certificate.
Tue, 16 Apr 2024
Compliance Certificate (RTA & Company) For The Financial Year Ended March 31 2024
PLEASE FIND ATTACHED CERTIFICATE PURSUANT TO REGULATION 7(3) of SEBI LODR
Mon, 15 Apr 2024
Corporate Presentation
Please find attached Corporate Presentation of the Company.

Morepen Laboratories Ltd. Technical Scans

View details >>
Tue, 16 Apr 2024
Closing Above Previous High Closing Above Previous High
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 5 Years High Increase in 5 Years

Morepen Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 368,765.79 1,536.95 -0.3%
Cipla Ltd. 111,101.58 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. 100,958.41 6,038.00 +0.5%
Divi's Laboratories Ltd. 99,939.63 3,755.15 +1.1%
Zydus Lifesciences Ltd. 95,104.21 937.80 +0.3%
Mankind Pharma Ltd. 91,420.29 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. 91,073.20 6,327.80 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.41 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-12 29.96 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.31 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 72.26 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.98 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-12 52.93 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.38 6,327.80 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.91 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-12 4.29 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.76 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-12 7.67 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.05 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-12 10.29 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.48 6,327.80 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,327.80 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,327.80 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,327.80 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,327.80 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,536.95 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,384.30 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,038.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,755.15 +1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 937.80 +0.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,295.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,327.80 +0.4%

Morepen Laboratories Ltd. FAQ's

What is Morepen Laboratories share price?
Can I buy Morepen Laboratories shares now?
What is the Market Cap of Morepen Laboratories?
What are the key metrics to analyse Morepen Laboratories?
What is the 52 Week High and Low of Morepen Laboratories?
What is the trend of Morepen Laboratories share price?